English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Ruth de Jauregui | Jun 7, 2017

Bristol-Myers Squibb, Novartis to study combination treatment for colorectal cancer

+ Technology/Innovation
Ruth de Jauregui | Jun 7, 2017

AstraZeneca sees positive results in treating BRCA-mutated breast cancer patients with Lynparza

+ Technology/Innovation
Ruth de Jauregui | Jun 4, 2017

National Institute of Health announces promising influenza study tool

+ Technology/Innovation
Tabitha Fleming | Jun 2, 2017

European Commission approves dinutuximab beta for treating high-risk neuroblastoma

+ Technology/Innovation
Ruth de Jauregui | Jun 2, 2017

Phase III trials of Ofev show positive results for idiopathic pulmonary fibrosis patients

+ Technology/Innovation
Carrice Quinnie | Jun 2, 2017

Celgene sees positive results in trial of oral ozanimod for relapsing multiple sclerosis

+ Technology/Innovation
LocalLabs News Service | May 31, 2017

K2M Group upgrades surgical device for spinal procedures

+ Technology/Innovation
Ruth de Jauregui | May 31, 2017

Boehringer Ingelheim trial shows tiotropium Respimat improves breathing for asthma patients

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily